Stock analysts at StockNews.com assumed coverage on shares of Orthofix Medical (NASDAQ:OFIX – Get Rating) in a research report issued on Friday. The brokerage set a “buy” rating on the medical device company’s stock.
Orthofix Medical Price Performance
Shares of OFIX stock opened at $17.64 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.06 and a quick ratio of 1.89. The company has a market capitalization of $352.98 million, a P/E ratio of -18.00 and a beta of 0.87. The company’s 50-day simple moving average is $20.54 and its two-hundred day simple moving average is $19.24. Orthofix Medical has a one year low of $13.76 and a one year high of $35.34.
Orthofix Medical (NASDAQ:OFIX – Get Rating) last announced its quarterly earnings results on Monday, March 6th. The medical device company reported $0.19 earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.56. Orthofix Medical had a negative net margin of 4.29% and a positive return on equity of 1.67%. The firm had revenue of $122.23 million during the quarter, compared to analysts’ expectations of $121.90 million. During the same quarter in the prior year, the company earned $0.27 EPS. As a group, equities analysts anticipate that Orthofix Medical will post -1.27 EPS for the current year.
Institutional Investors Weigh In On Orthofix Medical
About Orthofix Medical
Orthofix Medical, Inc engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion.
- Get a free copy of the StockNews.com research report on Orthofix Medical (OFIX)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.